392 G
Pill imprint 392 G has been identified as Carbidopa and levodopa CR 25 mg / 100 mg.
Carbidopa/levodopa is used in the treatment of parkinson's disease; restless legs syndrome; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy.
Carbidopa/levodopa 25 mg / 100 mg is not subject to the Controlled Substances Act.
See also related documents.
Carbidopa and levodopa CR Images
- Imprint:
-
392
G - Strength:
- 25 mg / 100 mg
- Color:
- Purple
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Dopaminergic antiparkinsonism agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Global Pharmaceuticals
- National Drug Code (NDC):
- 00115-3922
Advertisement
More Carbidopa and Levodopa CR resources
- Carbidopa/Levodopa (Wolters Kluwer)
- Carbidopa/Levodopa Orally Disintegrating Tablets (Wolters Kluwer)
- Carbidopa/Levodopa Sustained-Release Tablets (Wolters Kluwer)
- carbidopa and levodopa (Cerner Multum)
- Levodopa/Carbidopa (AHFS DI)
- Lodosyn (AHFS DI)
- Carbidopa and Levodopa (FDA)
- Carbidopa and Levodopa ODT (FDA)
- Carbidopa and Levodopa Tablets (FDA)
- Levodopa/Carbidopa (Wolters Kluwer)
Search Again
